Your browser doesn't support javascript.
The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
Woodruff, Trent M; Shukla, Arun K.
  • Woodruff TM; The School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane 4072, Australia; Queensland Brain Institute, The University of Queensland, Brisbane 4072, Australia. Electronic address: t.woodruff@uq.edu.au.
  • Shukla AK; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India. Electronic address: arshukla@iitk.ac.in.
Trends Immunol ; 41(11): 965-967, 2020 11.
Article in English | MEDLINE | ID: covidwho-834446

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Complement C5a / Coronavirus Infections / Receptor, Anaphylatoxin C5a / Betacoronavirus Limits: Animals / Humans Language: English Journal: Trends Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Complement C5a / Coronavirus Infections / Receptor, Anaphylatoxin C5a / Betacoronavirus Limits: Animals / Humans Language: English Journal: Trends Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article